Home/Filings/4/0001209191-17-027585
4//SEC Filing

BIOLASE, INC 4

Accession 0001209191-17-027585

CIK 0000811240operating

Filed

Apr 18, 8:00 PM ET

Accepted

Apr 19, 7:38 PM ET

Size

9.5 KB

Accession

0001209191-17-027585

Insider Transaction Report

Form 4
Period: 2017-04-18
Flynn Harold C Jr.
DirectorPresident and CEO
Transactions
  • Purchase

    Warrants (right to buy)

    2017-04-18$0.13/sh+14,945$1,86814,945 total(indirect: By Trust)
    Exercise: $1.80From: 2017-10-18Exp: 2022-04-18Common Stock (14,945 underlying)
  • Purchase

    Series D Participating Convertible Preferred Stock

    2017-04-18$124.00/sh+307$38,068307 total(indirect: By Trust)
    Common Stock (30,700 underlying)
Footnotes (4)
  • [F1]These shares of Series D Participating Convertible Preferred Stock ("Preferred Stock") and Warrants were acquired by the Flynn Living Trust (the "Trust") in a private placement with the Issuer that closed on April 18, 2017 (the "Closing").
  • [F2]Each share of Preferred Stock will initially be convertible into 100 shares of Common Stock ("Shares"), reflecting a conversion price equal to $1.24 per Share. The conversion of the Preferred Stock will occur automatically upon the Requisite Stockholder Approval (defined and described further in the Securities Purchase Agreement dated April 11, 2017 and filed as Exhibit 99.1 to the Current Report on Form 8-K filed by the Issuer on April 14, 2017), which is expected to occur after the Closing. The Preferred Stock has no expiration date.
  • [F3]The Preferred Stock and Warrants are held directly by the Trust. Mr. Flynn serves as a co-trustee to the Trust and his daughter is the beneficiary of the Trust.
  • [F4]The Reporting Person disclaims beneficial ownership of the Preferred Stock and Warrants except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the Preferred Stock or Warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Issuer

BIOLASE, INC

CIK 0000811240

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000811240

Filing Metadata

Form type
4
Filed
Apr 18, 8:00 PM ET
Accepted
Apr 19, 7:38 PM ET
Size
9.5 KB